Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome: Guidelines

International Journal of Urology

Volumn 16, Issue 7, 2009, Pages 597-615

  Homma, Yukio ^a   Ueda, Tomohiro ^b   Tomoe, Hikaru ^c   Lin, Alex Tl ^d   Kuo, Hann Chorng ^e   Lee, Ming Huei ^f   Lee, Jeong Gu ^g   Kim, Duk Yoon ^h   Lee, Kyu Sung ⁱ  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO CITY HOSPITAL   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

^g Korea University College of Medicine   (South Korea)

^h Department of Urology   (South Korea)

ⁱ Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bladder hypersensitivity; Guideline; Interstitial cystitis

Indexed keywords

AMITRIPTYLINE; AMOXICILLIN; ARGININE; BCG VACCINE; BIOLOGICAL MARKER; BOTULINUM TOXIN; CAPSAICIN; CHONDROITIN SULFATE; CIMETIDINE; CIPROFLOXACIN; CLINDAMYCIN; CYCLOSPORIN A; DIMETHYL SULFOXIDE; DOXYCYCLINE; ERYTHROMYCIN; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HISTAMINE; HYALURONIC ACID; HYDROXYZINE; INTERLEUKIN 6; LIDOCAINE; METRONIDAZOLE; OXYBUTYNIN; PENTOSAN POLYSULFATE; PLACEBO; PREDNISOLONE; RESINIFERATOXIN; RIFAMPICIN; SUPLATAST TOSYLATE;

ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; ALLERGY; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR THERAPY; BLADDER BIOPSY; BLADDER BLEEDING; BLADDER CANCER; BLADDER DISEASE; BLADDER EPITHELIUM; BLADDER RECONSTRUCTION; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CYSTALGIA; CYSTECTOMY; CYSTOSCOPY; DIAGNOSTIC TEST; DIARRHEA; DROWSINESS; DRUG EFFICACY; DRUG EXCRETION; DRUG INDUCED HEADACHE; DRUG MECHANISM; EMOTION; HAIR LOSS; HUMAN; HYPERBARIC OXYGEN; HYPERSENSITIVE BLADDER SYNDROME; HYPOXIA; INFECTION; INTERSTITIAL CYSTITIS; MAST CELL; NAUSEA; NEUROGENIC INFLAMMATION; NEUROMODULATION; NONHUMAN; PATHOGENESIS; PELVIS SURGERY; PHYSIOTHERAPY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TRANSCUTANEOUS NERVE STIMULATION; TRANSURETHRAL RESECTION; UNSPECIFIED SIDE EFFECT; URINARY DIVERSION; URINARY FREQUENCY; XEROSTOMIA;

CYSTITIS, INTERSTITIAL; HUMANS; PREVALENCE; URINATION DISORDERS; UROLOGY;

EID: 68249099454     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02326.x     Document Type: Review

References (332)

1. Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Clinical Guidelines for Interstitial Cystitis. Blackwell Publishing, Tokyo, 2007.
2. Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Japanese guideline for diagnosis and treatment of interstitial cystitis. Int. J. Urol. 2009 16 : 4 16.
3. International Consultation on Interstitial Cystitis Japan (ICICJ). Int. J. Urol. 2003 10 Suppl).
4. Comfortable Urology Network. 2nd ICICJ. Comfortable Urology Network, Kyoto, 2008.
5. Hanno P, Baranowski A, Fall M et al. Painful bladder syndrome (including interstitial cystitis). In : Abrams P, Cardozo L. Khoury S, Wein A (eds). Incontinence. Health Publication, St Helier, 2005 1455 520.
6. Fall M, Baranowski AP, Elneil S et al. Guidelines on chronic pelvic pain. In European Association of Urology Guidelines, 2008 edn. Available from URL: http://www.uroweb.org/files/uploaded-2326-files/guidelines/chronicpelvicpain.pdf
7. Parsons JK, Parsons CL. The historical origins of interstitial cystitis. J. Urol. 2004 171 : 20 2.
8. Hanno P, Nordling J, van Ophoven A. What is new in bladder pain syndrome/interstitial cystitis? Curr. Opin. Urol. 2008 18 : 353 8.
9. Goldman HB. Interstitial cystitis - the great enigma. J. Urol. 2000 164 : 1921.
10. Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J. Urol. 1999 161 : 553 7.
11. Sant GR, Hanno PM. Interstitial cystitis: current issues and controversies in diagnosis. Urology 2001 57 : 82 8.
12. Diokno AC, Homma Y, Sekiguchi Y, Suzuki Y. Interstitial cystitis, gynecologic pelvic pain, prostatitis, and their epidemiology. Int. J. Urol. 2003 10 (Suppl S3 6.
13. Leiby BE, Landis JR, Propert KJ, Tomaszewski JE. Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system. J. Urol. 2007 177 : 142 8.
14. Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J. Urol. 2007 177 : 450 6.
15. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 2002 21 : 167 78.
16. Abrams P, Baranowski A, Berger RE, Fall M, Hanno P, Wesselmann U. A new classification is needed for pelvic pain syndromes - are existing terminologies of spurious diagnostic authority bad for patients? J. Urol. 2006 175 : 1989 90.
17. Dalpiaz O, Kerschbaumer A, Mitterberger M, Pinggera G, Bartsch G, Strasser H. Chronic pelvic pain in women: still a challenge. BJU Int. 2008 102 : 1061 5.
18. van de Merwe JP, Nordling J, Bouchelouche P et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur. Urol. 2008 53 : 60 7.
19. Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between fibromyalgia and interstitial cystitis. J. Psychiatr. Res. 1997 31 : 125 31.
20. Warren JW, Meyer WA, Greenberg P, Horne L, Diggs C, Tracy JK. Using the International Continence Society's definition of painful bladder syndrome. Urology 2006 67 : 1138 42, discussion 1142 3.
21. International Association for the Study of Pain. Part III: Pain Terms: A Current List with Definitions and Notes on Usage. In : Merskey H Bogduk N (eds). Classification of Chronic Pain, 2nd edn, IASP Task Force on Taxonomy, IASP Press, Seattle, 1994 209 214.
22. Irwin P, Samsudin A. Reinvestigation of patients with a diagnosis of interstitial cystitis: common things are sometimes common. J. Urol. 2005 174 : 584 7, discussion 587.
23. Homma Y. Lower urinary tract symptomatology: its definition and confusion. Int. J. Urol. 2008 15 : 35 43.
24. Frazer MI, Haylen BT, Sissons M. Do women with idiopathic sensory urgency have early interstitial cystitis? Br. J. Urol. 1990 66 : 274 8.
25. Liu L, Mansfield KJ, Kristiana I, Vaux KJ, Millard RJ, Burcher E. The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder. Neurourol. Urodyn. 2007 26 : 433 8 discussion 439 discussion 451 3.
26. Apostolidis A, Gonzales GE, Fowler CJ. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur. Urol. 2006 50 : 1299 305.
27. Yamaguchi O, Honda K, Nomiya M et al. Defining overactive bladder as hypersensitivity. Neurourol. Urodyn. 2007 26 : 904 7.
28. Shear S, Mayer R. Development of glomerulations in younger women with interstitial cystitis. Urology 2006 68 : 253 6.
29. Furuya R, Masumori N, Furuya S, Oda T, Takahashi S, Takeuchi M. Glomerulation observed during transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is a common finding but no predictor of clinical outcome. Urology 2007 70 : 922 6.
30. Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J. Urol. 1998 160 : 1663 7.
31. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J. Urol. 1991 145 : 732 5.
32. Keay S, Kleinberg M, Zhang CO, Hise MK, Warren JW. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J. Urol. 2000 164 : 2112 18.
33. Keay S, Seillier-Moiseiwitsch F, Zhang CO, Chai TC, Zhang J. Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol. Genomics 2003 14 : 107 15.
34. Zhang CO, Wang JY, Koch KR, Keay S. Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. J. Urol. 2005 174 : 2382 7.
35. Laguna P, Smedts F, Nordling J et al. Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis. Am. J. Clin. Pathol. 2006 125 : 105 10.
36. Southgate J, Varley CL, Garthwaite MA et al. Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int. 2007 99 : 1506 16.
37. Zeng Y, Wu XX, Homma Y et al. Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis. J. Urol. 2007 178 : 1322 7 discussion 1327.
38. Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J. Urol. 2008 179 : 764 9.
39. Kumar V, Chapple CR, Surprenant AM, Chess-Williams R. Enhanced adenosine triphosphate release from the urothelium of patients with painful bladder syndrome: a possible pathophysiological explanation. J. Urol. 2007 178 : 1533 6.
40. Rastogi P, Rickard A, Dorokhov N, Klumpp DJ, McHowat J. Loss of prostaglandin E2 release from immortalized urothelial cells obtained from interstitial cystitis patient bladders. Am. J. Physiol. Renal Physiol. 2008 294 : F1129 35.
41. Erickson DR, Schwarze SR, Dixon JK, Clark CJ, Hersh MA. Differentiation associated changes in gene expression profiles of interstitial cystitis and control urothelial cells. J. Urol. 2008 180 : 2681 7.
42. Peeker R, Enerback L, Fall M, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J. Urol. 2000 163 : 1009 15.
43. Hofmeister MA, He F, Ratliff TL, Mahoney T, Becich MJ. Mast cells and nerve fibers in interstitial cystitis (IC): an algorithm for histologic diagnosis via quantitative image analysis and morphometry (QIAM). Urology 1997 49 : 41 7.
44. Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J. Urol. 1987 137 : 35 8.
45. Dundore PA, Schwartz AM, Semerjian H. Mast cell counts are not useful in the diagnosis of nonulcerative interstitial cystitis. J. Urol. 1996 155 : 885 7.
46. Ueda T, Tamaki M, Ogawa O, Yoshimura N. Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma. J. Urol. 2002 167 : 347 51.
47. Koskela LR, Thiel T, Ehren I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J. Urol. 2008 180 : 737 41.
48. Bouchelouche K, Bouchelouche P. Cysteinyl leukotriene D4 increases human detrusor muscle responsiveness to histamine. J. Urol. 2006 176 : 361 6.
49. Sakthivel SK, Singh UP, Singh S, Taub DD, Novakovic KR, Lillard JW Jr. CXCL10 blockade protects mice from cyclophosphamide-induced cystitis. J. Immune Based Ther. Vaccines 2008 6 : 6.
50. Domingue GJ, Ghoniem GM, Bost KL, Fermin C, Human LG. Dormant microbes in interstitial cystitis. J. Urol. 1995 153 : 1321 6.
51. Lynes W, Sellers R, Shortliffe L. The evidence for occult bacterial infections as a cause for interstitial cystitis. J. Urol. 1989 141 : 268A.
52. Duncan JL, Schaeffer AJ. Do infectious agents cause interstitial cystitis? Urology 1997 49 : 48 51.
53. Al-Hadithi HN, Williams H, Hart CA et al. Absence of bacterial and viral DNA in bladder biopsies from patients with interstitial cystitis/chronic pelvic pain syndrome. J. Urol. 2005 174 : 151 4.
54. Stanford E, McMurphy C. There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2007 18 : 551 4.
55. Warren JW, Brown V, Jacobs S, Horne L, Langenberg P, Greenberg P. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology 2008 71 : 1085 90.
56. Soler R, Bruschini H, Freire MP, Alves MT, Srougi M, Ortiz V. Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury. J. Urol. 2008 180 : 1527 31.
57. Parsons CL, Bautista SL, Stein PC, Zupkas P. Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J. Urol. 2000 164 : 1381 4.
58. Chu PS, Ma WK, Wong SC et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int. 2008 102 : 1616 22.
59. Nguan C, Franciosi LG, Butterfield NN, Macleod BA, Jens M, Fenster HN. A prospective, double-blind, randomized cross-over study evaluating changes in urinary pH for relieving the symptoms of interstitial cystitis. BJU Int. 2005 95 : 91 4.
60. Rosamilia A, Cann L, Scurry J, Rogers P, Dwyer P. Bladder microvasculature and the effects of hydrodistention in interstitial cystitis. Urology 2001 57 : 132.
61. Pontari MA, Hanno PM, Ruggieri MR. Comparison of bladder blood flow in patients with and without interstitial cystitis. J. Urol. 1999 162 : 330 4.
62. Yamada T, Nishimura M, Mita H. Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients. World J. Urol. 2007 25 : 407 13.
63. Peters KM, Carrico DJ, Diokno AC. Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome. Urology 2008 71 : 634 40.
64. Hall SA, Link CL, Pulliam SJ et al. The relationship of common medical conditions and medication use with symptoms of painful bladder syndrome: results from the Boston area community health survey. J. Urol. 2008 180 : 593 8.
65. Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig. Dis. Sci. 2008 53 : 1246 51.
66. Oravisto KJ. Interstitial cystitis as an autoimmune disease. A review. Eur. Urol. 1980 6 : 10 13.
67. Anderson JB, Parivar F, Lee G et al. The enigma of interstitial cystitis - an autoimmune disease? Br. J. Urol. 1989 63 : 58 63.
68. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 1989 44 : 93 151.
69. Ochs RL. Autoantibodies and interstitial cystitis. Clin. Lab. Med. 1997 17 : 571 9.
70. Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K, Auvinen A. Interstitial cystitis-like urinary symptoms among patients with Sjogren's syndrome: a population-based study in Finland. Am. J. Med. 2003 115 : 62 5.
71. Lin YH, Liu G, Kavran M et al. Lower urinary tract phenotype of experimental autoimmune cystitis in mouse: a potential animal model for interstitial cystitis. BJU Int. 2008 102 : 1724 30.
72. Lee J, Doggweiler-Wiygul R, Kim S, Hill BD, Yoo TJ. Is interstitial cystitis an allergic disorder? A case of interstitial cystitis treated successfully with anti-IgE. Int. J. Urol. 2006 13 : 631 4.
73. Imamov O, Yakimchuk K, Morani A et al. Estrogen receptor beta-deficient female mice develop a bladder phenotype resembling human interstitial cystitis. Proc. Natl Acad. Sci USA 2007 104 : 9806 9.
74. Christmas TJ, Rode J, Chapple CR, Milroy EJ, Turner-Warwick RT. Nerve fibre proliferation in interstitial cystitis. Virchows Arch. A Pathol. Anat. Histopathol. 1990 416 : 447 51.
75. Hohenfellner M, Nunes L, Schmidt RA, Lampel A, Thuroff JW, Tanagho EA. Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J. Urol. 1992 147 : 587 91.
76. Palea S, Artibani W, Ostardo E, Trist DG, Pietra C. Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J. Urol. 1993 150 : 2007 12.
77. Zermann DH, Ishigooka M, Doggweiler-Wiygul R, Schubert J, Schmidt RA. Central autonomic innervation of the kidney. What can we learn from a transneuronal tracing study in an animal model? J. Urol. 2005 173 : 1033 8.
78. Stefansson K, Wollmann RL, Moore BW. Distribution of S-100 protein outside the central nervous system. Brain Res. 1982 234 : 309 17.
79. Sugimura K, Haimoto H, Nagura H, Kato K, Takahashi A. Immunohistochemical differential distribution of S-100 alpha and S-100 beta in the peripheral nervous system of the rat. Muscle Nerve 1989 12 : 929 35.
80. Peeker R, Aldenborg F, Haglid K, Johansson SL, Rosengren L, Fall M. Decreased levels of S-100 protein in non-ulcer interstitial cystitis. Scand. J. Urol. Nephrol. 1998 32 : 395 8.
81. Peeker R, Aldenborg F, Dahlstrom A, Johansson SL, Li JY, Fall M. Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic and nonulcer interstitial cystitis. J. Urol. 2000 163 : 1112 15.
82. Elbadawi AE, Light JK. Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis. Urol. Int. 1996 56 : 137 62.
83. Chen MC, Blunt LW, Pins MR, Klumpp DJ. Tumor necrosis factor promotes differential trafficking of bladder mast cells in neurogenic cystitis. J. Urol. 2006 175 : 754 9.
84. Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J. Urol. 2004 172 : 1242 8.
85. Lutgendorf SK, Latini JM, Rothrock N, Zimmerman MB, Kreder KJ Jr. Autonomic response to stress in interstitial cystitis. J. Urol. 2004 172 : 227 31.
86. Fenton BW, Durner C, Fanning J. Frequency and distribution of multiple diagnoses in chronic pelvic pain related to previous abuse or drug-seeking behavior. Gynecol. Obstet. Invest. 2008 65 : 247 51.
87. Novi JM, Jeronis S, Srinivas S, Srinivasan R, Morgan MA, Arya LA. Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study. J. Urol. 2005 174 : 937 40.
88. Peters KM, Kalinowski SE, Carrico DJ, Ibrahim IA, Diokno AC. Fact or fiction - is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic population. J. Urol. 2007 178 : 891 5 discussion 895.
89. Link CL, Pulliam SJ, Hanno PM et al. Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston area community health survey. J. Urol. 2008 180 : 599 606.
90. Fan YH, Lin AT, Wu HM, Hong CJ, Chen KK. Psychological profile of Taiwanese interstitial cystitis patients. Int. J. Urol. 2008 15 : 416 18.
91. Clemens JQ, Brown SO, Calhoun EA. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J. Urol. 2008 180 : 1378 82.
92. Goldstein HB, Safaeian P, Garrod K, Finamore PS, Kellogg-Spadt S, Whitmore KE. Depression, abuse and its relationship to interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2008 19 : 1683 6.
93. Seth A, Teichman JM. Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse histology. J. Urol. 2008 180 : 2029 33.
94. Rothrock NE, Lutgendorf SK, Kreder KJ, Ratliff T, Zimmerman B. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology 2001 57 : 422 7.
95. Theoharides TC, Sant GR. Immunomodulators for treatment of interstitial cystitis. Urology 2005 65 : 633 8.
96. Theoharides TC, Pang X, Letourneau R, Sant GR. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann. N. Y. Acad. Sci. 1998 840 : 619 34.
97. Okragly AJ, Niles AL, Saban R et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J. Urol. 1999 161 : 438 41 discussion 441 2.
98. Abdel-Mageed AB, Ghoniem GM. Potential role of rel/nuclear factor-kappaB in the pathogenesis of interstitial cystitis. J. Urol. 1998 160 : 2000 3.
99. Dang K, Lamb K, Cohen M, Bielefeldt K, Gebhart GF. Cyclophosphamide- induced bladder inflammation sensitizes and enhances P2X receptor function in rat bladder sensory neurons. J. Neurophysiol. 2008 99 : 49 59.
100. Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis. Urology 2007 69 : 24 33.
101. Rudick CN, Chen MC, Mongiu AK, Klumpp DJ. Organ cross talk modulates pelvic pain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007 293 : R1191 8.
102. Oravisto KJ. Epidemiology of interstitial cystitis. Ann. Chir. Gynaecol. Fenn. 1975 64 : 75 7.
103. Leppilahti M, Tammela TL, Huhtala H, Auvinen A. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J. Urol. 2002 168 : 139 43.
104. Leppilahti M, Sairanen J, Tammela TL, Aaltomaa S, Lehtoranta K, Auvinen A. Prevalence of clinically confirmed interstitial cystitis in women: a population based study in Finland. J. Urol. 2005 174 : 581 3.
105. Temml C, Wehrberger C, Riedl C, Ponholzer A, Marszalek M, Madersbacher S. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur. Urol. 2007 51 : 803 8 discussion 809.
106. Jones C, Harris M, Nyberg L. Prevalence of interstitial cystitis in the United States. J. Urol. 1994 151 : 423A.
107. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J. Urol. 1999 161 : 549 52.
108. Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J. Urol. 2005 173 : 98 102 discussion 102.
109. Clemens JQ, Link CL, Eggers PW, Kusek JW, Nyberg LM Jr., McKinlay JB. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J. Urol. 2007 177 : 1390 4.
110. Ito T, Miki M, Yamada T. Interstitial cystitis in Japan. BJU Int. 2000 86 : 634 7.
111. Ito T, Ueda T, Honma Y, Takei M. Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients. Int. J. Urol. 2007 14 : 1068 70.
112. Homma Y, Yamaguchi O, Hayashi K. Epidemiologic survey of lower urinary tract symptoms in Japan. Urology 2006 68 : 560 4.
113. Kennedy CM, Bradley CS, Galask RP, Nygaard IE. Risk factors for painful bladder syndrome in women seeking gynecologic care. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2006 17 : 73 8.
114. Payne CK, Joyce GF, Wise M, Clemens JQ. Interstitial cystitis and painful bladder syndrome. J. Urol. 2007 177 : 2042 9.
115. Clemens JQ, Meenan RT, Rosetti MC, Kimes T, Calhoun EA. Costs of interstitial cystitis in a managed care population. Urology 2008 71 : 776 80 discussion 780 1.
116. Simon LJ, Landis JR, Erickson DR, Nyberg LM. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology 1997 49 : 64 75.
117. Michael YL, Kawachi I, Stampfer MJ, Colditz GA, Curhan GC. Quality of life among women with interstitial cystitis. J. Urol. 2000 164 : 423 7.
118. Rothrock NE, Lutgendorf SK, Kreder KJ. Coping strategies in patients with interstitial cystitis: relationships with quality of life and depression. J. Urol. 2003 169 : 233 6.
119. Homma Y. The symptoms of IC and QOL. Voiding Disorders Dig. 2004 12 : 15 22 In Japanese DP, Carr LK, Perks AE, Lee P, Teichman JM. Interstitial cystitis and female sexual dysfunction. Urology 2007 69 : 608 10.
120. Nickel JC, Tripp D, Teal V et al. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J. Urol. 2007 177 : 1832 6.
121. Nickel JC, Parsons CL, Forrest J et al. Improvement in sexual functioning in patients with interstitial cystitis/painful bladder syndrome. J. Sex. Med. 2008 5 : 394 9.
122. Gardella B, Porru D, Ferdeghini F et al. Insight into urogynecologic features of women with interstitial cystitis/painful bladder syndrome. Eur. Urol. 2008 54 : 1145 51.
123. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J. Urol. 1988 140 : 203 6.
124. Kusek JW, Nyberg LM. The epidemiology of interstitial cystitis: is it time to expand our definition? Urology 2001 57 : 95 9.
125. Dell JR. Chronic pelvic pain of bladder origin: a focus on interstitial cystitis. Int. J. Fertil. Womens Med. 2003 48 : 154 62.
126. Ajibona OO, Kehinde EO. Interstitial cystitis: a review of current concepts of aetiology, diagnosis and therapy. Scand. J. Urol. Nephrol. 2003 37 : 253 8.
127. Lutgendorf SK, Kreder KJ, Rothrock NE, Ratliff TL, Zimmerman B. Stress and symptomatology in patients with interstitial cystitis: a laboratory stress model. J. Urol. 2000 164 : 1265 9.
128. Greenberg P, Tracy JK, Meyer WA, Yates T, Diggs C, Warren JW. Short interval between symptom onset and medical care as an indication of rapid onset of interstitial cystitis/painful bladder syndrome. BJU Int. 2007 100 : 599 602 discussion 602.
129. O'Leary MP, Sant GR, Fowler FJ Jr., Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997 49 : 58 63.
130. Greenberg P, Brown J, Yates T, Brown V, Langenberg P, Warren JW. Voiding urges perceived by patients with interstitial cystitis/painful bladder syndrome. Neurourol. Urodyn. 2008 27 : 287 90.
131. Diggs C, Meyer WA, Langenberg P, Greenberg P, Horne L, Warren JW. Assessing urgency in interstitial cystitis/painful bladder syndrome. Urology 2007 69 : 210 14.
132. Sirinian E, Azevedo K, Payne CK. Correlation between 2 interstitial cystitis symptom instruments. J. Urol. 2005 173 : 835 40.
133. Propert KJ, Mayer RD, Wang Y et al. Responsiveness of symptom scales for interstitial cystitis. Urology 2006 67 : 55 9.
134. Kushner L, Moldwin RM. Efficiency of questionnaires used to screen for interstitial cystitis. J. Urol. 2006 176 : 587 92.
135. Warren JW, Brown J, Tracy JK, Langenberg P, Wesselmann U, Greenberg P. Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women. Urology 2008 71 : 444 8.
136. FitzGerald MP, Brensinger C, Brubaker L, Propert K. What is the pain of interstitial cystitis like? Int. Urogynecol. J. Pelvic Floor Dysfunct. 2006 17 : 69 72.
137. Warren JW, Langenberg P, Greenberg P, Diggs C, Jacobs S, Wesselmann U. Sites of pain from interstitial cystitis/painful bladder syndrome. J. Urol. 2008 180 : 1373 7.
138. Messing EM, Stamey TA. Interstitial cystitis: Early diagnosis, pathology, and treatment. Urology 1978 12 : 381 92.
139. Driscoll A, Teichman JM. How do patients with interstitial cystitis present? J. Urol. 2001 166 : 2118 20.
140. Stanford EJ, Mattox TF, Parsons JK, McMurphy C. Prevalence of benign microscopic hematuria among women with interstitial cystitis: implications for evaluation of genitourinary malignancy. Urology 2006 67 : 946 9.
141. Gomes CM, Sanchez-Ortiz RF, Harris C, Wein AJ, Rovner ES. Significance of hematuria in patients with interstitial cystitis: review of radiographic and endoscopic findings. Urology 2001 57 : 262 5.
142. Awad SA, MacDiarmid S, Gajewski JB, Gupta R. Idiopathic reduced bladder storage versus interstitial cystitis. J. Urol. 1992 148 : 1409 12.
143. Al-Hadithi H, Tincello DG, Vince GS, Richmond DH. Leukocyte populations in interstitial cystitis and idiopathic reduced bladder storage. Urology 2002 59 : 851 5.
144. Mukerji G, Waters J, Chessell IP, Bountra C, Agarwal SK, Anand P. Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders. BMC Urol. 2006 6 : 31.
145. Braunstein R, Shapiro E, Kaye J, Moldwin R. The role of cystoscopy in the diagnosis of Hunner's ulcer disease. J. Urol. 2008 180 : 1383 6.
146. Lamale LM, Lutgendorf SK, Hoffman AN, Kreder KJ. Symptoms and cystoscopic findings in patients with untreated interstitial cystitis. Urology 2006 67 : 242 5.
147. Ueda T, Nakagawa M, Okamura M, Tanoue H, Yoshida H, Yoshimura N. New cystoscopic diagnosis for interstitial cystitis/painful bladder syndrome using narrow-band imaging system. Int. J. Urol. 2008 15 : 1039 43.
148. Fall M, Aldenborg F, Johansson S, Peeker R. Clinical characteristics support that interstitial cystitis is a heterogeneous syndrome. Urology 2001 57 : 129 30.
149. Logadottir YR, Ehren I, Fall M, Wiklund NP, Peeker R, Hanno PM. Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J. Urol. 2004 171 : 1148 50 discussion 50 1.
150. Messing E, Pauk D, Schaeffer A et al. Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 1997 49 : 81 5.
151. Mattila J. Vascular immunopathology in interstitial cystitis. Clin. Immunol. Immunopathol. 1982 23 : 648 55.
152. Gillespie L, Said J, Sostrin S, Kleiwer K. Immunofluorescent and histochemical staining confirm the identification of the many diseases called interstitial cystitis. Br. J. Urol. 1990 66 : 265 73.
153. Lynes WL, Flynn SD, Shortliffe LD, Stamey TA. The histology of interstitial cystitis. Am. J. Surg. Pathol. 1990 14 : 969 76.
154. Rosamilia A, Igawa Y, Higashi S. Pathology of interstitial cystitis. Int. J. Urol. 2003 10 Suppl S11 15.
155. Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J. Urol. 1998 159 : 1862 6 discussion 1866 7.
156. Chambers GK, Fenster H. Re: the role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J. Urol. 1999 161 : 1581 2.
157. Gregoire M, Liandier F, Naud A, Lacombe L, Fradet Y. Does the potassium stimulation test predict cystometric, cystoscopic outcome in interstitial cystitis? J. Urol. 2002 168 : 556 7.
158. Philip J, Willmott S, Irwin P. Interstitial cystitis versus detrusor overactivity: a comparative, randomized, controlled study of cystometry using saline and 0.3 M potassium chloride. J. Urol. 2006 175 : 566 70 discussion 570 1.
159. Sairanen J, Tammela TL, Leppilahti M, Onali M, Forsell T, Ruutu M. Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium. Neurourol. Urodyn. 2007 26 : 267 70.
160. Philip J, Willmott S, Owen D, Samsudin C, Irwin PP. A double-blind, randomized controlled trial of cystometry using saline versus 0.3 M potassium chloride infusion in women with overactive bladder syndrome. Neurourol. Urodyn. 2007 26 : 110 14.
161. Keay SK, Szekely Z, Conrads TP et al. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc. Natl Acad. Sci USA 2004 101 : 11803 8.
162. Keay S, Zhang CO, Chai T et al. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004 63 : 22 6.
163. Erickson DR, Kunselman AR, Bentley CM et al. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J. Urol. 2007 177 : 556 60.
164. Sun Y, Chen M, Lowentritt BH et al. EGF and HB-EGF modulate inward potassium current in human bladder urothelial cells from normal and interstitial cystitis patients. Am. J. Physiol. Cell Physiol. 2007 292 : C106 14.
165. Hosseini A, Ehren I, Wiklund NP. Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis. J. Urol. 2004 172 : 2261 5.
166. Lamale LM, Lutgendorf SK, Zimmerman MB, Kreder KJ. Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. Urology 2006 68 : 702 6.
167. Canter MP, Graham CA, Heit MH et al. Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects. Am. J. Obstet. Gynecol. 2008 198 : 553 e1 6.
168. Kuromitsu S, Yokota H, Hiramoto M, Morita S, Mita H, Yamada T. Increased concentration of neutrophil elastase in urine from patients with interstitial cystitis. Scand. J. Urol. Nephrol. 2008 1 7.
169. Erickson DR, Tomaszewski JE, Kunselman AR et al. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J. Urol. 2008 179 : 1850 6.
170. Fall M, Oberpenning F, Peeker R. Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions? Eur. Urol. 2008 54 : 65 75.
171. Chaiken DC, Blaivas JG, Blaivas ST. Behavioral therapy for the treatment of refractory interstitial cystitis. J. Urol. 1993 149 : 1445 8.
172. Parsons CL, Koprowski PF. Interstitial cystitis: successful management by increasing urinary voiding intervals. Urology 1991 37 : 207 12.
173. Koziol JA, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J. Urol. 1993 149 : 465 9.
174. McCormick N. Psychological Aspects of Interstitial Cystitis, in Sant G: Interstitial Cystitis. Lippincott-Raven, Philadelphia, PA, 1997 193 2003.
175. Webster DC, Brennan T. Self-care effectiveness and health outcomes in women with interstitial cystitis: implications for mental health clinicians. Iss. Ment. Health Nurs. 1998 19 : 495 519.
176. Carrico DJ, Peters KM, Diokno AC. Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study. J. Altern. Complement. Med. 2008 14 : 53 60.
177. Whitmore KE. Self-care regimens for patients with interstitial cystitis. Urol. Clin. North Am. 1994 21 : 121 30.
178. Chung MK. Interstitial cystitis in persistent posthysterectomy chronic pelvic pain. JSLS 2004 8 : 329 33.
179. Nickel JC. Interstitial cystitis. Etiology, diagnosis, and treatment. Can. Fam. Physician 2000 46 : 2430 4, 2437 40.
180. Gillespie L. Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br. J. Urol. 1993 72 : 293 7.
181. Moldwin RM, Sant GR. Interstitial cystitis: a pathophysiology and
182. Shorter B, Lesser M, Moldwin RM, Kushner L. Effect of comestibles on symptoms of interstitial cystitis. J. Urol. 2007 178 : 145 52.
183. Webster DC, Brennan T. Self-care strategies used for acute attack of interstitial cystitis. Urol. Nurs. 1995 15 : 86 93.
184. Webster DC, Brennan T. Use and effectiveness of physical self-care strategies for interstitial cystitis. Nurse Pract. 1994 19 : 55 61.
185. Bade JJ, Peeters JM, Mensink HJ. Is the diet of patients with interstitial cystitis related to their disease? Eur. Urol. 1997 32 : 179 83.
186. Koziol JA. Epidemiology of interstitial cystitis. Urol. Clin. North Am. 1994 21 : 7 20.
187. Erickson DR, Davies MF. Interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1998 9 : 174 83.
188. Mendelowitz F, Moldwin R. Complementary approaches in the management of interstitial cystitis. In : Sant G (ed.). Interstitial Cystitis. Lippincott-Raven, Philadelphia, PA, 1997 235 9.
189. Lukban J, Whitmore K, Kellogg-Spadt S, Bologna R, Lesher A, Fletcher E. The effect of manual physical therapy in patients diagnosed with interstitial cystitis, high-tone pelvic floor dysfunction, and sacroiliac dysfunction. Urology 2001 57 : 121 2.
190. Holzberg A, Kellog-Spadt S, Lukban J, Whitmore K. Evaluation of transvaginal theile massage as a therapeutic intervention for women with interstitial cystitis. Urology 2001 57 : 120.
191. Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J. Urol. 2001 166 : 2226 31.
192. Markwell SJ. Physical therapy management of pelvi/perineal and perianal pain syndromes. World J. Urol. 2001 19 : 194 9.
193. Meadows E. Treatments for patients with pelvic pain. Urol. Nurs. 1999 19 : 33 5.
194. Lukban JC, Whitmore KE. Pelvic floor muscle re-education treatment of the overactive bladder and painful bladder syndrome. Clin. Obstet. Gynecol. 2002 45 : 273 85.
195. Barrington JW, Stephenson TP. Pentosanpolysulphate for interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1997 8 : 293 5.
196. Parsons CL, Schmidt JD, Pollen JJ. Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J. Urol. 1983 130 : 51 3.
197. Fritjofsson A, Fall M, Juhlin R, Persson BE, Ruutu M. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J. Urol. 1987 138 : 508 12.
198. Holm-Bentzen M, Jacobsen F, Nerstrom B et al. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J. Urol. 1987 138 : 503 7.
199. Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology 1990 35 : 552 8.
200. Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J. Urol. 1993 150 : 845 8.
201. Nickel JC, Barkin J, Forrest J et al. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 2005 65 : 654 8.
202. Nickel JC, Kaufman DM, Zhang HF, Wan GJ, Sand PK. Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. Urology 2008 71 : 57 61.
203. Hanno PM, Wein AJ. Medical treatment of interstitial cystitis (other than Rimso-50/Elmiron). Urology 1987 29 : 22 6.
204. Hanno PM, Wein AJ. Conservative therapy of interstitial cystitis. Semin. Urol. 1991 9 : 143 7.
205. Pranikoff K, Constantino G. The use of amitriptyline in patients with urinary frequency and pain. Urology 1998 51 : 179 81.
206. Kirkemo A, Miles B, Peters J. Use of amitriptyline in interstitial cystitis. J. Urol. 1990 143 : 279A.
207. van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J. Urol. 2004 172 : 533 6.
208. van Ophoven A, Hertle L. Long-term results of amitriptyline treatment for interstitial cystitis. J. Urol. 2005 174 : 1837 40.
209. Nishijima S, Sugaya K, Yamada T, Miyazato M, Ogawa Y. Efficacy of tricyclic antidepressant is associated with beta2-adrenoceptor genotype in patients with interstitial cystitis. Biomed. Res. 2006 27 : 163 7.
210. Minogiannis P, El-Mansoury M, Betances JA, Sant GR, Theoharides TC. Hydroxyzine inhibits neurogenic bladder mast cell activation. Int. J. Immunopharmacol. 1998 20 : 553 63.
211. Simmons JL, Bunce PL. On the use of an antihistamine in the treatment of interstitial cystitis. Am. Surg. 1958 24 : 664 7.
212. Simmons J. Interstitial cystitis: an explanation for the beneficial effect of an antihistamine. J. Urol. 1961 85 : 149 55.
213. Theoharides TC. Hydroxyzine for interstitial cystitis. J. Allergy Clin. Immunol. 1993 91 : 686 7.
214. Theoharides TC. Hydroxyzine in the treatment of interstitial cystitis. Urol. Clin. North Am. 1994 21 : 113 19.
215. Sant GR, Propert KJ, Hanno PM et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J. Urol. 2003 170 : 810 15.
216. Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T. J. Urol. 2000 164 : 1917 20.
217. Boucher W, Kempuraj D, Cao J, Papaliodis D, Theoharides TC. Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation. J. Urol. 2007 177 : 1186 90.
218. Kirimoto T, Nakano K, Irimura K et al. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid. BJU Int. 2007 100 : 935 9.
219. Forsell T, Ruutu M, Isoniemi H, Ahonen J, Alfthan O. Cyclosporine in severe interstitial cystitis. J. Urol. 1996 155 : 1591 3.
220. Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J. Urol. 2004 171 : 2138 41.
221. Sairanen J, Tammela TL, Leppilahti M et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J. Urol. 2005 174 : 2235 8.
222. Sairanen J, Hotakainen K, Tammela TL, Stenman UH, Ruutu M. Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium. Urology 2008 71 : 630 3.
223. Badenoch AW. Chronic interstitial cystitis. Br. J. Urol. 1971 43 : 718 21.
224. Soucy F, Gregoire M. Efficacy of prednisone for severe refractory ulcerative interstitial cystitis. J. Urol. 2005 173 : 841 3 discussion 843.
225. Seshadri P, Emerson L, Morales A. Cimetidine in the treatment of interstitial cystitis. Urology 1994 44 : 614 16.
226. Lewi H. Cimetidine in treatment of interstitial cystitis. Urology 1995 45 : 1088.
227. Lewi H. Medical therapy in interstitial cystitis: the Essex experience. Urology 2001 57 : 120.
228. Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001 87 : 207 12.
229. Warren JW, Horne LM, Hebel JR, Marvel RP, Keay SK, Chai TC. Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis. J. Urol. 2000 163 : 1685 8.
230. Smith SD, Wheeler MA, Foster HE Jr., Weiss RM. Improvement in interstitial cystitis symptom scores during treatment with oral L-arginine. J. Urol. 1997 158 : 703 8.
231. Ehren I, Lundberg JO, Adolfsson J, Wiklund NP. Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis. Urology 1998 52 : 1026 9.
232. Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster HE Jr. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis. J. Urol. 1999 161 : 558 65.
233. Cartledge JJ, Davies AM, Eardley I. A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis. BJU Int. 2000 85 : 421 6.
234. Birder LA, Kanai AJ, de Groat WC. DMSO: effect on bladder afferent neurons and nitric oxide release. J. Urol. 1997 158 : 1989 95.
235. Peeker R, Haghsheno MA, Holmang S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J. Urol. 2000 164 : 1912 15 discussion 1915 16.
236. Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J. Urol. 1988 140 : 36 9.
237. Ruiz JL, Alonso M, Moreno B, Server G, Osca JM, Jimenez JF Dimethyl sulfoxide in the treatment of interstitial cystitis Actas Urol. Esp. 1991 15 : 357 60.
238. Fowler JE Jr. Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitis. Urology 1981 18 : 21 6.
239. Rossberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand. J. Urol. Nephrol. 2005 39 : 73 7.
240. Sant GR. Intravesical 50% dimethyl sulfoxide (Rimso-50) in treatment of interstitial cystitis. Urology 1987 29 : 17 21.
241. Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br. J. Urol. 1994 73 : 504 7.
242. Kuo HC. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis. J. Formos. Med. Assoc. 2001 100 : 309 14.
243. Welk BK, Teichman JM. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology 2008 71 : 67 70.
244. Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005 65 : 45 8.
245. Leppilahti M, Hellstrom P, Tammela TL. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 2002 60 : 46 51.
246. Porru D, Campus G, Tudino D et al. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol. Int. 1997 59 : 26 9.
247. Morales A, Emerson L, Nickel JC. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 1997 49 : 111 13.
248. Morales A, Emerson L, Nickel JC, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J. Urol. 1996 156 : 45 8.
249. Kallestrup EB, Jorgensen SS, Nordling J, Hald T. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product. Scand. J. Urol. Nephrol. 2005 39 : 143 7.
250. Iavazzo C, Athanasiou S, Pitsouni E, Falagas ME. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur. Urol. 2007 51 : 1534 40 discussion 1540 1.
251. Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pfluger H. Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2008 19 : 717 21.
252. Steinhoff G, Ittah B, Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can. J. Urol. 2002 9 : 1454 8.
253. Nickel JC, Egerdie B, Downey J et al. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int. 2009 103 : 56 60.
254. Nordling J, van Ophoven A. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial. Arzneimittelforschung 2008 58 : 328 35.
255. Cervigni M, Natale F, Nasta L, Padoa A, Voi RL, Porru D. A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2008 19 : 943 7.
256. Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J. Urol. 2008 179 : 177 85.
257. Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J. Urol. 2008 179 : 177 85.
258. Barbalias GA, Liatsikos EN, Athanasopoulos A, Nikiforidis G. Interstitial cystitis: bladder training with intravesical oxybutynin. J. Urol. 2000 163 : 1818 22.
259. Riedl CR, Knoll M, Plas E, Pfluger H. Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis. J. Endourol. 1998 12 : 269 72.
260. Rosamilia A, Dwyer PL, Gibson J. Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1997 8 : 142 5.
261. Riedl CR, Knoll M, Plas E, Stephen RL, Pfluger H. Intravesical electromotive drug administration for the treatment of non-infectious chronic cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1997 8 : 134 7.
262. Gurpinar T, Wong HY, Griffith DP. Electromotive administration of intravesical lidocaine in patients with interstitial cystitis. J. Endourol. 1996 10 : 443 7.
263. Fagerli J, Fraser MO, deGroat WC et al. Intravesical capsaicin for the treatment of interstitial cystitis: a pilot study. Can. J. Urol. 1999 6 : 737 44.
264. Lazzeri M, Spinelli M, Beneforti P, Malaguti S, Giardiello G, Turini D. Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: a pilot study. Eur. Urol. 2004 45 : 98 102.
265. Takahashi S, Yanase M, Inoue R et al. Intravesical instillation of resiniferatoxin for the patients with interstitial cystitis Hinyokika Kiyo 2006 52 : 911 13.
266. Peng CH, Kuo HC. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis. Urol. Int. 2007 78 : 78 81.
267. Payne CK, Mosbaugh PG, Forrest JB et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J. Urol. 2005 173 : 1590 4.
268. Chen TY, Corcos J, Camel M, Ponsot Y, Tu le M. Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC). Int. Urogynecol. J. Pelvic Floor Dysfunct. 2005 16 : 293 7.
269. Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB. Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J. Urol. 2004 172 : 1529 32.
270. Lucioni A, Bales GT, Lotan TL, McGehee DS, Cook SP, Rapp DE. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int. 2008 101 : 366 70.
271. Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology 2004 64 : 871 5 discussion 875.
272. Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur. Urol. 2006 49 : 704 9.
273. Liu HT, Kuo HC. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 2007 70 : 463 8.
274. Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year follow up. J. Urol. 2008 179 : 1031 4.
275. Aghamir SM, Mohseni MG, Arasteh S. Intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis. Urol. J. 2007 4 : 18 23.
276. Peters K, Diokno A, Steinert B et al. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J. Urol. 1997 157 : 2090 4.
277. Peters KM, Diokno AC, Steinert BW, Gonzalez JA. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term follow up. J. Urol. 1998 159 : 1483 6 discussion 1486 7.
278. Zeidman EJ, Helfrick B, Pollard C, Thompson IM. Bacillus Calmette-Guerin immunotherapy for refractory interstitial cystitis. Urology 1994 43 : 121 4.
279. Mayer R, Propert KJ, Peters KM et al. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J. Urol. 2005 173 : 1186 91.
280. Propert KJ, Mayer R, Nickel JC et al. Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin? J. Urol. 2007 178 : 886 90.
281. Bade JJ, Rijcken B, Mensink HJ. Interstitial cystitis in The Netherlands: prevalence, diagnostic criteria and therapeutic preferences. J. Urol. 1995 154 : 2035 7 discussion 2037 8.
282. Rovner E, Propert KJ, Brensinger C et al. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology 2000 56 : 940 5.
283. Bumpus HJ. Interstitial cystitis: its treatment by over-distention of the bladder. Med. Clin. North Am. 1930 13 : 1495 8.
284. Yamada T, Murayama T, Andoh M. Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis. Int. J. Urol. 2003 10 : 463 8 discussion 469.
285. Dunn M, Ramsden PD, Roberts JB, Smith JC, Smith PJ. Interstitial cystitis, treated by prolonged bladder distension. Br. J. Urol. 1977 49 : 641 5.
286. Glemain P, Riviere C, Lenormand L, Karam G, Bouchot O, Buzelin JM. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur. Urol. 2002 41 : 79 84.
287. Tomoe H, Kobayashi H, Nakazawa H, Toma H. The efficacy of hydrodistension of the bladder for interstitial cystitis. J. Interst. Cyst. 2004 2 : 24 31.
288. Gosling JA, Dixon JS, Dunn M. The structure of the rabbit urinary bladder after experimental distension. Invest. Urol. 1977 14 : 386 9.
289. Taub HC, Stein M. Bladder distention therapy for symptomatic relief of frequency and urgency: a ten-year review. Urology 1994 43 : 36 9.
290. Higson RH, Smith JC, Whelan P. Bladder rupture: an acceptable complication of distension therapy? Br. J. Urol. 1978 50 : 529 34.
291. Zabihi N, Allee T, Maher MG et al. Bladder necrosis following hydrodistention in patients with interstitial cystitis. J. Urol. 2007 177 : 149 52 discussion 152.
292. Uchida E, Ishimaru R, Mukubo Y, Tomoe H, Nakazawa H, Kawamata M. Patient satisfaction with anesthesia for hydrodistension during perioperative period. Nippon Hinyokika Gakkai Zasshi 2005 96 : 274.
293. Fall M. Conservative management of chronic interstitial cystitis: transcutaneous electrical nerve stimulation and transurethral resection. J. Urol. 1985 133 : 774 8.
294. Fall M, Lindstrom S. Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis. Urol. Clin. North Am. 1994 21 : 131 9.
295. Geirsson G, Wang YH, Lindstrom S, Fall M. Traditional acupuncture and electrical stimulation of the posterior tibial nerve. A trial in chronic interstitial cystitis. Scand. J. Urol. Nephrol. 1993 27 : 67 70.
296. Bristow SE, Hasan ST, Neal DE. TENS: a treatment option for bladder dysfunction. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1996 7 : 185 90.
297. Zhao J, Bai J, Zhou Y, Qi G, Du L. Posterior tibial nerve stimulation twice a week in patients with interstitial cystitis. Urology 2008 71 : 1080 4.
298. Whitmore KE, Payne CK, Diokno AC, Lukban JC. Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2003 14 : 305 8 discussion 308 9.
299. Peters KM. Neuromodulation for the treatment of refractory interstitial cystitis. Rev. Urol. 2002 4 (Suppl 1 S36 43.
300. Maher CF, Carey MP, Dwyer PL, Schluter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J. Urol. 2001 165 : 884 6.
301. Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J. Urol. 2003 169 : 1369 73.
302. Zermann DH, Weirich T, Wunderlich H, Reichelt O, Schubert J. Sacral nerve stimulation for pain relief in interstitial cystitis. Urol. Int. 2000 65 : 120 1.
303. Steinberg AC, Oyama IA, Whitmore KE. Bilateral S3 stimulator in patients with interstitial cystitis. Urology 2007 69 : 441 3.
304. Peters KM, Feber KM, Bennett RC. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007 100 : 835 9.
305. Chang PL. Urodynamic studies in acupuncture for women with frequency, urgency and dysuria. J. Urol. 1988 140 : 563 6.
306. Chang PL, Wu CJ, Huang MH. Long-term outcome of acupuncture in women with frequency, urgency and dysuria. Am. J. Chin Med. 1993 21 : 231 6.
307. O'Reilly BA, Dwyer PL, Hawthorne G et al. Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis. J. Urol. 2004 172 : 1880 3.
308. Tanaka T, Kawashima H, Makino T, Kamikawa S, Kato N, Nakatani T. Hyperbaric oxygen therapy for interstitial cystitis resistant to conventional treatments. Int. J. Urol. 2007 14 : 563 5.
309. van Ophoven A, Rossbach G, Pajonk F, Hertle L. Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial. J. Urol. 2006 176 : 1442 6.
310. Kerr WS Jr. Interstitial cystitis: treatment by transurethral resection. J. Urol. 1971 105 : 664 6.
311. Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2000 11 : 290 5.
312. Greenberg E, Barnes R, Stewart S, Furnish T. Transurethral resection of Hunner's ulcer. J. Urol. 1974 111 : 764 6.
313. Kaneko T, Fujita K, Homma Y Clinical experience on 52 patients with interstitial cystitis Nippon Hinyokika Gakkai Zasshi 2006 97 : 771 6.
314. Shanberg AM, Baghdassarian R, Tansey LA. Treatment of interstitial cystitis with the neodymium-YAG laser. J. Urol. 1985 134 : 885 8.
315. Shanberg AM, Malloy T. Treatment of interstitial cystitis with neodymium:YAG laser. Urology 1987 29 : 31 3.
316. Malloy TR, Shanberg AM. Laser therapy for interstitial cystitis. Urol. Clin. North Am. 1994 21 : 141 4.
317. Rofeim O, Hom D, Freid RM, Moldwin RM. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J. Urol. 2001 166 : 134 6.
318. van Ophoven A, Oberpenning F, Hertle L. Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis. J. Urol. 2002 167 : 603 7.
319. Irwin PP, Galloway NT. Surgical management of interstitial cystitis. Urol. Clin. North Am. 1994 21 : 145 51.
320. Linn JF, Hohenfellner M, Roth S et al. Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution. J. Urol. 1998 159 : 774 8.
321. Kontturi MJ, Hellstrom PA, Tammela TL, Lukkarinen OA. Colocystoplasty for the treatment of severe interstitial cystitis. Urol. Int. 1991 46 : 50 4.
322. Nielsen KK, Kromann-Andersen B, Steven K, Hald T. Failure of combined supratrigonal cystectomy and Mainz ileocecocystoplasty in intractable interstitial cystitis: is histology and mast cell count a reliable predictor for the outcome of surgery? J. Urol. 1990 144 : 255 8 discussion 258 9.
323. Peeker R, Aldenborg F, Fall M. The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J. Urol. 1998 159 : 1479 82.
324. Rossberger J, Fall M, Jonsson O, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology 2007 70 : 638 42.
325. Nurse DE, Parry JR, Mundy AR. Problems in the surgical treatment of interstitial cystitis. Br. J. Urol. 1991 68 : 153 4.
326. Chakravarti A, Ganta S, Somani B, Jones MA. Caecocystoplasty for intractable interstitial cystitis: long-term results. Eur. Urol. 2004 46 : 114 17.
327. Gershbaum D, Moldwin R. Practice trends for the management of interstitial cystitis. Urology 2001 57 : 119.
328. Baskin LS, Tanagho EA. Pelvic pain without pelvic organs. J. Urol. 1992 147 : 683 6.
329. Blaivas JG, Weiss JP, Desai P, Flisser AJ, Stember DS, Stahl PJ. Long-term follow up of augmentation enterocystoplasty and continent diversion in patients with benign disease. J. Urol. 2005 173 : 1631 4.
330. Elzawahri A, Bissada NK, Herchorn S et al. Urinary conduit formation using a retubularized bowel from continent urinary diversion or intestinal augmentations: ii. Does it have a role in patients with interstitial cystitis? J. Urol. 2004 171 : 1559 62.
331. Freiha FS, Faysal MH, Stamey TA. The surgical treatment of intractable interstitial cystitis. J. Urol. 1980 123 : 632 4.
332. Propert KJ, Payne C, Kusek JW, Nyberg LM. Pitfalls in the design of clinical trials for interstitial cystitis. Urology 2002 60 : 742 8.